Stockreport

Acer Therapeutics Announces In-license of Osanetant from Sanofi

Acer Therapeutics Inc.  (ACER) 
Last acer therapeutics inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: acertx.com/investor-relations
PDF NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercial [Read more]